Corcept Therapeutics Incorporated Stock Price on November 12, 2024

CORT Stock  USD 72.77  1.29  1.80%   
If you're considering investing in Corcept Stock, it is important to understand the factors that can impact its price. As of today, the current price of Corcept Therapeutics stands at 72.77, as last reported on the 2nd of May, with the highest price reaching 74.22 and the lowest price hitting 71.17 during the day. Corcept Therapeutics appears to be not too volatile, given 3 months investment horizon. Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0552, which signifies that the company had a 0.0552 % return per unit of risk over the last 3 months. By analyzing Corcept Therapeutics' technical indicators, you can evaluate if the expected return of 0.8% is justified by implied risk. Please makes use of Corcept Therapeutics' Mean Deviation of 4.86, downside deviation of 5.06, and Risk Adjusted Performance of 0.1127 to double-check if our risk estimates are consistent with your expectations.
At this time, Corcept Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 882.6 M in 2025, whereas Common Stock Total Equity is likely to drop slightly above 87.7 K in 2025. . At this time, Corcept Therapeutics' Price Earnings Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 8.04 in 2025, whereas Price To Sales Ratio is likely to drop 7.32 in 2025. Corcept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book
11.427
Enterprise Value Ebitda
53.4342
Price Sales
11.2919
Shares Float
87 M
Wall Street Target Price
143.25

Related Headline

Mineralys Therapeutics, Headline on 12th of November 2024

Operator Greetings. Welcome to Mineralys Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Corcept Therapeutics Valuation on November 12, 2024

It is possible to determine the worth of Corcept Therapeutics on a given historical date. On November 12, 2024 Corcept was worth 59.0 at the beginning of the trading date compared to the closed value of 57.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Corcept Therapeutics stock. Still, in general, we apply an absolute valuation method to find Corcept Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corcept Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Corcept Therapeutics' related companies.
 Open High Low Close Volume
  59.88    60.05    58.02    59.06    1,220,255  
11/12/2024
  59.00    59.98    57.00    57.79    1,166,217  
  58.02    59.26    56.41    56.45    581,496  
Backtest Corcept Therapeutics  |  Corcept Therapeutics History  |  Corcept Therapeutics Valuation   PreviousNext  

Open Value

59.0
57.79
Closing Value
102.42
Upside

Corcept Therapeutics Trading Date Momentum on November 12, 2024

On November 13 2024 Corcept Therapeutics Incorporated was traded for  56.45  at the closing time. The top price for the day was 59.26  and the lowest listed price was  56.41 . The trading volume for the day was 581.5 K. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.32% . The overall trading delta against the current closing price is 2.75% .

Corcept Therapeutics Fundamentals Correlations and Trends

By evaluating Corcept Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Corcept financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Corcept Therapeutics Stock history

Corcept Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corcept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corcept Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corcept Therapeutics stock prices may prove useful in developing a viable investing in Corcept Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding113.5 M84.9 M
Net Income Applicable To Common Shares116.5 M122.3 M

Corcept Therapeutics Quarterly Net Working Capital

330.83 Million

Corcept Therapeutics Stock Technical Analysis

Corcept Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Corcept Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Corcept Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Corcept Therapeutics Period Price Range

Low
May 2, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Corcept Therapeutics Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Corcept Therapeutics May 2, 2025 Market Strength

Market strength indicators help investors to evaluate how Corcept Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corcept Therapeutics shares will generate the highest return on investment. By undertsting and applying Corcept Therapeutics stock market strength indicators, traders can identify Corcept Therapeutics Incorporated entry and exit signals to maximize returns

Corcept Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Corcept Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Corcept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corcept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Corcept Stock Analysis

When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.